معرفی
Anne H Blaes is a Professor of Medicine at the University of Minnesota School of Medicine, specializing in Hematology, Oncology, and Transplantation. She is also affiliated with the Center for Women's Health Research, demonstrating her commitment to women's health issues within oncology.
Her research interests focus on the critical intersection of oncology and cardiovascular health (cardio-oncology), breast cancer (particularly triple-negative breast cancer), cancer survivorship, and women's health. Dr. Blaes has established herself as a leading expert in understanding how cancer treatments affect cardiovascular health and how to optimize care for cancer survivors.
Analysis of her recent publications reveals a strong emphasis on the connections between cancer and cardiovascular disease, survivorship care models, and quality of life issues for cancer patients. Her work spans clinical trials, epidemiological studies, and patient-centered outcomes research, with significant contributions to clinical practice guidelines in cardio-oncology.
- Minnesota Nathan Shock Center of Excellence on Genome Integrity and Aging (2025-2030)
- UNTOLD: Understanding The experience of Ovarian cancer (2024-2026)
- Understanding the impact of survivorship care plans on health outcomes in cancer survivors (2024-2025)
- OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients (2024-2035)
- Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab for Triple Negative Breast Cancer (2024-2034)
Dr. Blaes has been actively involved in mentoring and training the next generation of oncology researchers and clinicians. Her funding portfolio demonstrates strong support from major institutions including NIH, CDC, and pharmaceutical partners, indicating the significance and impact of her research program. She has also engaged with the media to provide expert commentary on cancer survivorship issues, including commentary on Ruth Bader Ginsburg's cancer journey.
